Literature DB >> 12677428

Current and prospective understanding of clinical classification, pathomechanisms and therapy in pemphigus.

Yasuo Kitajima1.   

Abstract

Mesh：

Year:  2003        PMID： 12677428     DOI： 10.1007/s00403-002-0368-1

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN： 0340-3696            Impact factor:   3.017


× No keyword cloud information.
  5 in total

1.  Bucillamine-induced pemphigus vulgaris in a patient with rheumatoid arthritis and polymyositis overlap syndrome.

Authors:  Jin-Wuk Hur; Chang-Woo Lee; Dae-Hyun Yoo
Journal:  J Korean Med Sci       Date:  2006-06       Impact factor: 2.153

Review 2.  A perspective of pemphigus from bedside and laboratory-bench.

Authors:  Yasuo Kitajima; Yumi Aoyama
Journal:  Clin Rev Allergy Immunol       Date:  2007-10       Impact factor: 8.667

3.  Shifting Focus in the Therapeutics of Immunobullous Disease.

Authors:  Abhishek De; Asad Ansari; Nidhi Sharma; Aarti Sarda
Journal:  Indian J Dermatol       Date:  2017 May-Jun       Impact factor: 1.494

4.  Pemphigus: use of the Japanese severity index in 56 Moroccan patients.

Authors:  Hakima Benchikhi; Samira Nani; Hanane Baybay; Said Amal; Fatim-Zahra Mernissi
Journal:  Pan Afr Med J       Date:  2013-11-14

Review 5.  Biologics in dermatology: an integrated review.

Authors:  Virendra N Sehgal; Deepika Pandhi; Ananta Khurana
Journal:  Indian J Dermatol       Date:  2014-09       Impact factor: 1.494
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.